Constellation Brands offers asymmetric long-term upside as premium beer leadership and lower capex drive cash generation, despite near-term depletion, margin, tariff, and regional demand risks.
Overview
Constellation Brands is a premium beverage-alcohol company whose investment case is dominated by a structurally advantaged Beer segment and an improving, streamlined Wine & Spirits portfolio. Modelo Especial, Corona Extra, Pacifico, and Victoria give STZ leadership in U.S. premium import beer, with Modelo the number-one beer brand by dollar sales and the Beer segment consistently taking 0.4-0.6 share points annually. Q1 FY2027 enterprise sales declined 3.3% to $2.433 billion because approximately $142 million of divested sales disappeared, but organic sales rose 3%. Comparable EPS increased 7% to $3.43 and exceeded consensus by 6.85%; Beer sales rose 2% to $2.284 billion, while Wine & Spirits organic sales grew 8%. **The near-term issue is a 0.3% Beer depletion decline versus 1.8% shipment growth**, alongside H2 FY2027 logistics, packaging, and regional demand risks. Management nevertheless guides to $11.20-$11.90 comparable EPS, $1.6-$1.7 billion FCF, and approximately $800 million capex. **The builder-to-operator transition is the central catalyst**, with cash redirected toward buybacks and debt reduction. At $120.98, the stock is below a $172 median analyst target and the report’s $254.88 five-year probability-weighted value.